Cerebral Adrenoleukodystrophy Pipeline Insight 2024, Featuring Key Players Minoryx Therapeutics, POXEL, Orpheris and Bluebird bio
April 17, 2024 05:50 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "Cerebral Adrenoleukodystrophy - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...